Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 3/2018

01-07-2018 | Correction

Corrections to: Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries

Authors: Anne Brédart, Jean‑Luc Kop, Antonis C. Antoniou, Alex P. Cunningham, Antoine De Pauw, Marc Tischkowitz, Hans Ehrencrona, Sylvie Dolbeault, Léonore Robieux, Kerstin Rhiem, Douglas F. Easton, Peter Devilee, Dominique Stoppa‑Lyonnet, Rita Schmutlzer

Published in: Familial Cancer | Issue 3/2018

Login to get access

Excerpt

The article “Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries” written by Anne Brédart · Jean‑Luc Kop · Antonis C. Antoniou · Alex P. Cunningham · Antoine De Pauw · Marc Tischkowitz · Hans Ehrencrona · Sylvie Dolbeault · Léonore Robieux · Kerstin Rhiem · Douglas F. Easton · Peter Devilee · Dominique Stoppa‑Lyonnet · Rita Schmutlzer, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 16th June 2017 without open access. …
Metadata
Title
Corrections to: Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
Authors
Anne Brédart
Jean‑Luc Kop
Antonis C. Antoniou
Alex P. Cunningham
Antoine De Pauw
Marc Tischkowitz
Hans Ehrencrona
Sylvie Dolbeault
Léonore Robieux
Kerstin Rhiem
Douglas F. Easton
Peter Devilee
Dominique Stoppa‑Lyonnet
Rita Schmutlzer
Publication date
01-07-2018
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2018
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0051-5

Other articles of this Issue 3/2018

Familial Cancer 3/2018 Go to the issue

Review

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge

Original Article

Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine

Letter to the Editor

Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations

Short Communication

Penetrance of a rare familial mutation predisposing to papillary thyroid cancer

Review

An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review

Short Communication

Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits